Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-050070
Filing Date
2021-08-05
Accepted
2021-08-05 21:17:40
Documents
2
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9524
2 EX-24 DOCUMENT attachment1.htm EX-24 3771
  Complete submission text file 0001209191-21-050070.txt   14701
Mailing Address C/O ARSANIS, INC. 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address
Gerngross Tillman U. (Reporting) CIK: 0001722061 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40703 | Film No.: 211150331

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)